ProfileGDS5678 / 1416636_at
TitleAnti-VEGF and Anti-Notch treatment effect on U87 glioblastoma xenograft tumors [Mouse430_2]
OrganismMus musculus


control bevacizumab dibenzazepine GSM967852 GSM967853 GSM967854 GSM967855 GSM967856 GSM967862 GSM967863 GSM967864 GSM967865 GSM967857 GSM967858 GSM967859 GSM967860 GSM967861 98% 98% 98% 97% 98% 98% 98% 98% 98% 98% 98% 98% 98% 98% sort by agent Gene Expression Profile
Graph caption help
SampleTitleValueRank
GSM967852U87-EV human glioblastoma xenograft - Control 19.8858198
GSM967853U87-EV human glioblastoma xenograft - Control 29.9451398
GSM967854U87-EV human glioblastoma xenograft - Control 310.114398
GSM967855U87-EV human glioblastoma xenograft - Control 49.7240197
GSM967856U87-EV human glioblastoma xenograft - Control 59.9160298
GSM967862U87-EV human glioblastoma xenograft - Bevacizumab treated 19.6598498
GSM967863U87-EV human glioblastoma xenograft - Bevacizumab treated 29.5122498
GSM967864U87-EV human glioblastoma xenograft - Bevacizumab treated 39.5976598
GSM967865U87-EV human glioblastoma xenograft - Bevacizumab treated 49.7186298
GSM967857U87-EV human glioblastoma xenograft - dibenzazepine treated 19.830198
GSM967858U87-EV human glioblastoma xenograft - dibenzazepine treated 29.8250298
GSM967859U87-EV human glioblastoma xenograft - dibenzazepine treated 39.8300898
GSM967860U87-EV human glioblastoma xenograft - dibenzazepine treated 49.840398
GSM967861U87-EV human glioblastoma xenograft - dibenzazepine treated 59.8075298